CRW.L

Craneware Plc
Craneware plc - Posting of Annual Report and Notice of AGM
16th October 2024, 16:05
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4891I
Craneware plc
16 October 2024
 

 

Craneware plc

 

("Craneware" or the "Company" or the "Group")

 

Posting of Annual Report and Notice of AGM

 

 

16 October 2024 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to confirm that the Annual Report and Accounts for the year ended 30 June 2024, together with the Notice of Annual General Meeting ("AGM") and a Form of Proxy, have been posted to shareholders and are available on the Company's website at www.thecranewaregroup.com.

 

The Company's AGM will be held at the offices of Craneware plc, 1 Tanfield, Edinburgh, EH3 5DA, UK, on 13 November 2024 at 10am.

 

 

For further information, please contact:

 

 

Craneware plc                                                                                      +44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial PR)                                                                             +44 (0)20 3405 0205

Caroline Forde, Kinvara Verdon                                                             craneware@almastrategic.com

Peel Hunt (NOMAD and Joint Broker)                                                   +44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne

Investec Bank PLC (Joint Broker)                                                         +44 (0)20 7597 5970

Patrick Robb, Henry Reast, Shalin Bhamra

Berenberg (Joint Broker)                                                                      +44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

About Craneware

The Craneware Group (AIM:CRW.L), is the market leader in value cycle solutions. For 25 years, we have collaborated with U.S. healthcare providers to optimize revenue integrity, pricing intelligence, decision support, labor productivity, business of pharmacy, and 340B program management. 

 

Customers choose Trisus®, a HITRUST- and SOC2 Type II-certified, SaaS platform, to achieve operational and financial excellence in pursuit of their healthcare mission - delivering quality care to their communities. The Craneware Group - Transforming the Business of Healthcare.

 

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAQQLFFZBLBFBX]]>
TwitterFacebookLinkedIn